Status:
NOT_YET_RECRUITING
7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Hepatic Encephalopathy (HE)
MRI
Eligibility:
All Genders
18-89 years
Brief Summary
This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).
Detailed Description
In this study, we analyzed the imaging characteristics of HE. First, with the advantages of 7TMRI, we analyzed the differences in imaging characteristics between HE patients and the healthy, including...
Eligibility Criteria
Inclusion
- Patients with clinical suspected or diagnosed hepatic encephalopathy according to relevant guidelines.The patient's education level is above primary school level.
- Regular follow-up.
Exclusion
- Contraindications to MRI.
- Patients with cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease.
Key Trial Info
Start Date :
April 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 24 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06923254
Start Date
April 3 2025
End Date
December 24 2030
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853